Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank of Montreal (BMO) vs Stryker Corporation (SYK) Price & Performance

Bank of MontrealTrade
Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Bank of Montreal vs Stryker Corporation — how do they compare? Bank of Montreal trades at $180.81 (market cap $125.53B), while Stryker Corporation trades at $309.2 (market cap $119.25B). The key difference: Bank of Montreal and Stryker Corporation are close in size by market cap, and Bank of Montreal pays the higher dividend (2.74%). Which is the better fit depends on your goals.

BMOSYK
Market Cap
$125.53B$119.25B
Sector
FinancialsTechnology
52-Week High
$180.86$403.53
52-Week Low
$110.44$282.58
Dividend Yield
2.74%1.13%
Enterprise Value
$131.01B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Bank of Montreal

BMO trades at $178.69, down 0.15% today, with a bullish technical signal supported by moving averages and key resistance at $180. The company reported strong Q1 2026 earnings of $2.68 per share, beating estimates, and maintains a solid net income margin of 25.92%. Recent acquisitions and dividend increases highlight strategic growth, while analyst sentiment is balanced with 44% buy ratings.

Outlook remains positive driven by consistent earnings beats and expansion in metals & mining banking. Risks include valuation above historical norms with a P/E of 19.48 and exposure to interest rate sensitivity. The stock offers a compelling dividend yield but faces macroeconomic headwinds that could pressure future performance.

Stryker Corporation

Stryker (SYK) trades at $331.45, up 0.51% today, with strong analyst support (74% buy ratings) and a consensus price target of $388.44. The stock shows bullish technical signals despite a recent Q1 2026 earnings miss attributed to a temporary cyber disruption. Fundamentals remain solid with 2025 revenue of $25.12B, net income margin of 13.21%, and robust cash flow generation of $5.04B from operations.

Outlook remains positive with maintained full-year guidance and healthy end-market demand. Investment opportunity lies in the valuation discount to historical averages and innovation-driven growth. Key risks include cybersecurity vulnerabilities and competitive pressures in the medtech sector. The stock offers potential upside of 17% to consensus target with dividend stability as a Dividend Aristocrat.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Bank of Montreal

Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, U.S. P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.

Read more on BMO

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK